SENS (Eversense) Company Projected Revenue

Brandmark of Senseonics Holdings Inc (SENS)

Senseonics Holdings (SENS) minimizes risks by developing long-term implantable glucose sensors for the global market. The assessment of the organization's prospective sales on GURU.Markets reflects capital dynamics, where 0.06 serves as the current metric level. The issuer is implementing ESG standards, reducing medical waste through packaging optimization. The company is currently experiencing active growth as it promotes the innovative Eversense system for people with diabetes.

SENS - Senseonics Holdings Company Expected Sales Volume over the range 07/04/2022 - 11/18/2026

Analytical breakdowns and data insights for company Senseonics Corp (SENS)

Fundamental company analysis:senseonics.com
Brand item of Senseonics Holdings Inc

This metric aggregates the market consensus for expected revenue, allowing for an assessment of capital density within the asset and a comparison of current quotes against actual financial targets. The trend in the company's future sales levels serves as a portfolio stress-testing tool, revealing margin risks for Senseonics (SENS) amid fierce competition with Dexcom and Abbott and a high dependency on external R&D funding.

Analysis of competing companies

Company Future Sales Volume DXCM (Dexcom)|Company Future Sales Volume Penumbra PEN|Company Projected Revenue Novanta Photonics NOVT|Haemonetics Corp. (HAE) - Company Expected Sales Volume|Inspire Medical - Projected Sales Volume|Company Expected Sales Volume PROCEPT BioRobotics|CNMD: Projected Sales Volume|Company Revenue Forecast PLSE|INMD (InMode MD) - Projected Sales Volume|Company Future Sales Volume Picard Medical Inc. (PMI)|Projected Sales Volume SRDX|Company Future Sales Volume NeuroPace, Inc. NPCE|Projected Sales Volume TCMD (Tactile Systems Technology, Inc.)|Projected Sales Volume SANUWAVE Health SNWV|outsetmedical.com - Projected Sales Volume|ELMD: Company Projected Revenue|LNSR (LENSAR, Inc.) - Company Future Sales Volume|AVITA Medical, Inc. - Company Future Revenue|PROF (Profound Medical Corp) - Projected Sales Volume|Company Expected Sales Volume bairdmed.com BDMD|Company Projected Revenue EDAP TMS (EDAP)|Bovie Medical (APYX) - Company Sales Forecast|IceCure Medical Ltd. - Company Future Sales Volume|Projected Sales Volume Pulmonx Corp. LUNG|TELA Bio Inc. - Projected Sales Volume|Company Future Sales CytoSorbents Corporation CTSO|Sensus Healthcare (SRTS) - Company Projected Revenue|Company Expected Revenue ZYXI (Zynex Corp)|Company Projected Revenue electrocore.com|Company Future Sales Volume Vicarious Surgical Inc. (RBOT)|Projected Sales Volume IINN|SeaStar Medical Holding Corp - Company Revenue Forecast|Company Projected Revenue iridex.com IRIX|INBS: Company Revenue Forecast|XAIR: Company Future Sales Volume|profusa.com - Company Projected Revenue Volume|STRATA Skin Sciences (SSKN) - Company Projected Revenue|Company Sales Forecast glucotrack.com GCTK|NAOV (nanovibronix.com) - Projected Sales Volume|Company Expected Sales Volume Venus Concept Corporation VERO|Company Future Sales Volume NUWE (nuwellis.com)|Company Projected Revenue Volume AEMD|Company Projected Revenue asensus.com ASXC|AVGR: Company Revenue Forecast|BioSig Technologies, Inc - Projected Sales Volume|Company Future Revenue CUTR (Cutera, Inc)|KNW: Projected Sales Volume|inarimedical.com - Company Future Revenue|NVRO (Nevro Corp) - Projected Sales Volume|Company Expected Sales Volume ReShape Lifesciences Inc. RSLS|Projected Sales Volume SILK